Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers

Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers

Saved in:
Bibliographic Details
Published in:Human gene therapy Vol. 16; no. 9; p. 1016
Main Author: Peng, Zhaohui
Format: Journal Article
Language:English
Published: United States 01-09-2005
Subjects:
Adenoviridae - genetics
China
Clinical Trials as Topic - statistics & numerical data
Female
Genetic Therapy - methods
Genetic Therapy - trends
Genetic Vectors - adverse effects
Genetic Vectors - genetics
Genetic Vectors - therapeutic use
Humans
Male
Neoplasms - genetics
Neoplasms - therapy
Quality Control
Research Support as Topic - trends
Treatment Outcome
Tumor Suppressor Protein p53 - adverse effects
Tumor Suppressor Protein p53 - genetics
Tumor Suppressor Protein p53 - therapeutic use
China
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1043-0342
DOI:10.1089/hum.2005.16.1016